VEGFA and neoplasm: Conversely, in patients with a more favorable genetic profile, the microenvironment conditions due to the different genotype combinations may result in a reduction of the VEGF production and in the presence of fewer VEGFR-2, or of its lower activity, on tumor endothelial cells which are not capable to proliferate, migrate or survive.